Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer

Loss of androgen receptor (AR) signaling dependence occurs in approximately 15%–20% of advanced treatment-resistant prostate cancers, and this may manifest clinically as transformation from a prostate adenocarcinoma histology to a castration-resistant neuroendocrine prostate cancer (CRPC-NE). The di...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Invest
Main Authors: Beltran, Himisha, Romanel, Alessandro, Conteduca, Vincenza, Casiraghi, Nicola, Sigouros, Michael, Franceschini, Gian Marco, Orlando, Francesco, Fedrizzi, Tarcisio, Ku, Sheng-Yu, Dann, Emma, Alonso, Alicia, Mosquera, Juan Miguel, Sboner, Andrea, Xiang, Jenny, Elemento, Olivier, Nanus, David M., Tagawa, Scott T., Benelli, Matteo, Demichelis, Francesca
格式: Artigo
語言:Inglês
出版: American Society for Clinical Investigation 2020
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108892/
https://ncbi.nlm.nih.gov/pubmed/32091413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI131041
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍